Skip to main content
Fig. 5 | Critical Care

Fig. 5

From: Implications of cardiac markers in risk-stratification and management for COVID-19 patients

Fig. 5

Severe/critical COVID-19 patients with abnormal cardiac markers exhibited higher mortality. a Percent of abnormal cardiac markers in patients with and without pre-existing CAD. b Expression of SARS-CoV-2 receptors, TMPRSS2 and ENPEP, in coronary artery disease and healthy controls. c The mortality rate of COVID-19 patients with cardiac markers abnormality. de Median levels of cardiac markers in survivors and non-survivors during hospitalization. ***P < 0.001; NS: not significant

Back to article page